FindTrial
Sign In

Study for the predict role of blood routine test and serum biochemical indexes for the effect assessment of advanced non-small cell lung cancer radiotherapy

Study for the predict role of blood routine test and serum biochemical indexes for the effect assessment of advanced non-small cell lung cancer radiotherapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-PRC-16010054
Enrollment
Unknown
Registered
2016-11-30
Start date
2016-12-05
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

local advanced NSCLC

Interventions

2:blood test

Sponsors

Affiliated hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. before radiotherapy patients blood; 2. aged 18 to 80 years old; 3. clear lung cancer diagnosis, stage IIIA, IIIB.

Exclusion criteria

Exclusion criteria: can't complete radiotherapy patients

Design outcomes

Primary

MeasureTime frame
PFS;OS;—

Countries

china

Contacts

Public ContactHu Ma

Affiliated hospital of Zunyi Medical University

mahuab@163.com+86 18311543939

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026